Neogen Corp (NEOG)
12.46
+0.20
(+1.67%)
USD |
NASDAQ |
May 02, 16:00
12.46
0.00 (0.00%)
After-Hours: 20:00
Neogen Revenue (Quarterly): 228.81M for Feb. 29, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 228.81M |
| November 30, 2023 | 229.63M |
| August 31, 2023 | 228.99M |
| May 31, 2023 | 241.81M |
| February 28, 2023 | 218.26M |
| November 30, 2022 | 230.03M |
| August 31, 2022 | 132.35M |
| May 31, 2022 | 140.09M |
| February 28, 2022 | 128.24M |
| November 30, 2021 | 130.52M |
| August 31, 2021 | 128.30M |
| May 31, 2021 | 127.42M |
| February 28, 2021 | 116.71M |
| November 30, 2020 | 115.00M |
| August 31, 2020 | 109.32M |
| May 31, 2020 | 109.07M |
| February 29, 2020 | 99.87M |
| November 30, 2019 | 107.80M |
| August 31, 2019 | 101.42M |
| May 31, 2019 | 109.76M |
| February 28, 2019 | 97.70M |
| November 30, 2018 | 107.10M |
| August 31, 2018 | 99.63M |
| May 31, 2018 | 108.12M |
| February 28, 2018 | 94.90M |
| Date | Value |
|---|---|
| November 30, 2017 | 100.70M |
| August 31, 2017 | 94.21M |
| May 31, 2017 | 95.53M |
| February 28, 2017 | 88.38M |
| November 30, 2016 | 90.72M |
| August 31, 2016 | 83.64M |
| May 31, 2016 | 90.08M |
| February 29, 2016 | 76.72M |
| November 30, 2015 | 79.61M |
| August 31, 2015 | 74.86M |
| May 31, 2015 | 78.61M |
| February 28, 2015 | 68.41M |
| November 30, 2014 | 68.46M |
| August 31, 2014 | 67.60M |
| May 31, 2014 | 67.26M |
| February 28, 2014 | 62.00M |
| November 30, 2013 | 59.60M |
| August 31, 2013 | 58.55M |
| May 31, 2013 | 56.01M |
| February 28, 2013 | 51.06M |
| November 30, 2012 | 50.74M |
| August 31, 2012 | 49.73M |
| May 31, 2012 | 48.54M |
| February 29, 2012 | 44.91M |
| November 30, 2011 | 44.89M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
99.87M
Minimum
Feb 2020
241.81M
Maximum
May 2023
151.67M
Average
128.27M
Median
Revenue (Quarterly) Benchmarks
| Moderna Inc | 2.813B |
| SIGA Technologies Inc | 116.48M |
| Syros Pharmaceuticals Inc | 0.386M |
| Disc Medicine Inc | -- |
| Amylyx Pharmaceuticals Inc | 108.45M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.022M |
| Total Expenses (Quarterly) | 216.79M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 3.373B |
| Gross Profit Margin (Quarterly) | 51.08% |
| Profit Margin (Quarterly) | -0.88% |
| Earnings Yield | 0.05% |
| Operating Earnings Yield | 2.56% |
| Normalized Earnings Yield | 0.1688 |